AVELOX 400 Bayer at a Glance
AVELOX 400 Bayer is a pharmaceutical-grade moxifloxacin hydrochloride compound available exclusively for in-vitro laboratory research applications. This fourth-generation fluoroquinolone antibiotic compound demonstrates broad-spectrum antimicrobial activity in research settings, making it valuable for microbiological studies and pharmaceutical research protocols. Moxifloxacin exhibits excellent tissue penetration characteristics in preclinical models and maintains stability across various research conditions. When investigating antimicrobial mechanisms in laboratory environments, researchers at Stroid UK Shop have access to this pharmaceutical-grade reference standard for comparative studies and analytical method development.
Laboratory Investigation Parameters
Research scientists examine moxifloxacin’s mechanism of action through its inhibition of bacterial DNA gyrase and topoisomerase IV enzymes in controlled laboratory settings. The compound demonstrates potent activity against gram-positive and gram-negative bacterial strains in culture media, with particular efficacy observed against respiratory pathogens in microbiological assays. Analytical laboratories investigate its pharmacokinetic properties, including high oral bioavailability and extensive tissue distribution characteristics. Studies examining resistance mechanisms utilize this compound to evaluate bacterial adaptation patterns and cross-resistance development in controlled experimental conditions. For researchers exploring fluoroquinolone pharmacology, our research chemical inventory provides consistent supply chains for ongoing investigations.
Technical Specifications
| Parameter | Value |
|---|---|
| Compound Name | Moxifloxacin HCl |
| Molecular Formula | C₂₁H₂₄FN₃O₄ · HCl |
| Molecular Weight | 437.89 g/mol |
| CAS Number | 186826-86-8 |
| Purity | Pharmaceutical grade |
| Storage Conditions | Room temperature, dry conditions |
| Solubility | Water soluble |
| Research Applications | Antimicrobial studies, analytical reference |
Laboratory protocols require precise handling procedures when examining this fluoroquinolone compound’s antimicrobial spectrum against various bacterial isolates. Researchers investigating antibiotic resistance mechanisms benefit from this compound’s well-characterized inhibition profiles against DNA replication enzymes. Quality control laboratories utilize pharmaceutical-grade moxifloxacin for method validation and calibration curve development in analytical chemistry applications. Our selective androgen receptor modulators complement antimicrobial research programs requiring diverse compound libraries. Additionally, peptide research programs often incorporate fluoroquinolone standards when examining compound interactions, available through our peptide research collection for comprehensive laboratory investigations.
Research Compliance Statement
AVELOX 400 Bayer moxifloxacin compound is manufactured exclusively for in-vitro research applications and laboratory analytical procedures. This pharmaceutical reference standard is not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate laboratory safety protocols when handling fluoroquinolone compounds and ensure compliance with institutional research guidelines. All antimicrobial research activities must be conducted within controlled laboratory environments by qualified research personnel. This product is intended solely for scientific investigation, analytical method development, and microbiological research purposes under professional laboratory supervision.
